DK0918874T3 - Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression - Google Patents
Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspressionInfo
- Publication number
- DK0918874T3 DK0918874T3 DK97937661T DK97937661T DK0918874T3 DK 0918874 T3 DK0918874 T3 DK 0918874T3 DK 97937661 T DK97937661 T DK 97937661T DK 97937661 T DK97937661 T DK 97937661T DK 0918874 T3 DK0918874 T3 DK 0918874T3
- Authority
- DK
- Denmark
- Prior art keywords
- self
- specific gene
- provide tissue
- gene expression
- expression vectors
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title abstract 3
- 239000013604 expression vector Substances 0.000 title abstract 2
- 230000007774 longterm Effects 0.000 abstract 1
- 230000002085 persistent effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16241—Use of virus, viral particle or viral elements as a vector
- C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Ceramics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Telephonic Communication Services (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9617214.3A GB9617214D0 (en) | 1996-08-16 | 1996-08-16 | Vector |
US2504096P | 1996-08-28 | 1996-08-28 | |
PCT/GB1997/002213 WO1998007876A2 (fr) | 1996-08-16 | 1997-08-18 | Vecteurs d'expression episomiques autoreproducteurs conferant une expression genique specifique de tissus |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0918874T3 true DK0918874T3 (da) | 2001-05-14 |
Family
ID=26309883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97937661T DK0918874T3 (da) | 1996-08-16 | 1997-08-18 | Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0918874B1 (fr) |
JP (1) | JP2000516472A (fr) |
AT (1) | ATE199570T1 (fr) |
AU (1) | AU725474B2 (fr) |
CA (1) | CA2263796A1 (fr) |
DE (1) | DE69704206T2 (fr) |
DK (1) | DK0918874T3 (fr) |
ES (1) | ES2157084T3 (fr) |
GR (1) | GR3035838T3 (fr) |
PT (1) | PT918874E (fr) |
WO (1) | WO1998007876A2 (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399383B1 (en) * | 1997-10-28 | 2002-06-04 | Maxygen, Inc. | Human papilloma virus vectors |
WO2000005393A2 (fr) | 1998-07-21 | 2000-02-03 | Cobra Therapeutics Limited | Polynucleotide comportant un element d'ouverture de la chromatine ubiquiste (ucoe) |
ES2375266T3 (es) | 1998-07-21 | 2012-02-28 | Millipore Corporation | Un polinucleótido que comprende un elemento de apertura de cromatina ubicuo (ucoe). |
US6417002B1 (en) * | 1999-02-11 | 2002-07-09 | Pharmacopeia, Inc. | Method for maintenance and selection of episomes |
DE19942149A1 (de) * | 1999-09-03 | 2001-03-15 | Daniele Zink | Verfahren zur Expression von exogenen Sequenzen in Säugerzellen |
AU783128B2 (en) | 2000-03-02 | 2005-09-29 | Innovata Plc | TCF responsive element |
AU9006701A (en) | 2000-09-20 | 2002-04-02 | Cobra Therapeutics Ltd | Polynucleotide |
US7812148B2 (en) | 2001-04-05 | 2010-10-12 | Millipore Corporation | Vectors comprising CpG islands without position effect varigation and having increased expression |
JP2005500019A (ja) | 2001-04-05 | 2005-01-06 | エムエル ラボラトリーズ ピーエルシー | 改良された遺伝子発現 |
PL206097B1 (pl) * | 2001-05-03 | 2010-06-30 | Fit Biotech Oyj Plc | Wektor ekspresyjny, jego zastosowanie, sposób wytwarzania tego wektora, komórka gospodarza, kompozycja farmaceutyczna, szczepionka DNA, genowy czynnik terapeutyczny oraz sposób wytwarzania szczepionki DNA |
FI116851B (fi) | 2001-05-03 | 2006-03-15 | Fit Biotech Oyj Plc | Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita |
GB2384001B (en) | 2001-12-14 | 2004-02-04 | Asterion Ltd | Chimeric growth hormone-growth hormone receptor proteins |
CA2487206A1 (fr) | 2002-10-07 | 2004-04-15 | Ludwig Institute Cancer Research | Polypeptide |
DE602004027789D1 (de) | 2003-02-01 | 2010-08-05 | Millipore Corp | Verbesserte genetische elemente für eine erhöhte genexpression |
FI116068B (fi) | 2003-09-15 | 2005-09-15 | Fit Biotech Oyj Plc | Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi |
GB0328690D0 (en) | 2003-12-10 | 2004-01-14 | Ludwig Inst Cancer Res | Tumour suppressor protein |
GB0406330D0 (en) * | 2004-03-20 | 2004-04-21 | Univ Sheffield | Gene screen |
GB0509965D0 (en) | 2005-05-17 | 2005-06-22 | Ml Lab Plc | Improved expression elements |
EP2118270A2 (fr) | 2007-01-08 | 2009-11-18 | Millipore Corporation | Méthodes de culture cellulaire destinées à la production de protéines recombinées en présence de niveaux réduits d'un ou plusieurs contaminants |
EP2571998B1 (fr) * | 2010-05-19 | 2017-06-07 | Icosagen Cell Factory OÜ | Procédé et trousse pour l'identification de composés capables d'inhiber la réplication du papillomavirus humain |
JP5863338B2 (ja) | 2011-08-25 | 2016-02-16 | 株式会社東芝 | プラスミド型ベクター、遺伝子プロモーター活性の検出方法、及びアッセイキット |
US10654908B2 (en) | 2014-04-15 | 2020-05-19 | University Of Virginia Patent Foundation | Isolated T cell receptors and methods of use therefor |
GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
WO2020018715A1 (fr) | 2018-07-17 | 2020-01-23 | Massachusetts Institute Of Technology | Protéines de fusion à base d'échafaudage d'immunoglobuline multimère soluble et leurs utilisations |
JP2022513113A (ja) | 2018-11-26 | 2022-02-07 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫寛容のための組成物および方法 |
TW202128775A (zh) | 2019-10-16 | 2021-08-01 | 英商阿法克塔生命科學有限公司 | PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分 |
GB202101299D0 (en) | 2020-06-09 | 2021-03-17 | Avacta Life Sciences Ltd | Diagnostic polypetides and methods |
WO2022043686A1 (fr) | 2020-08-25 | 2022-03-03 | Thrombosis Research Institute | Vaccin |
GB2606693A (en) | 2021-04-08 | 2022-11-23 | Exosis Inc | Fusion protein |
WO2022234003A1 (fr) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Polypeptides se liant à cd33 avec protéine stefin a |
GB202107057D0 (en) | 2021-05-18 | 2021-06-30 | Univ York | Glycosylation method |
TW202334196A (zh) | 2021-10-07 | 2023-09-01 | 英商阿法克塔生命科學有限公司 | Pd-l1結合多肽 |
WO2023057946A1 (fr) | 2021-10-07 | 2023-04-13 | Avacta Life Sciences Limited | Polypeptides sériques de liaison pd-l1 prolongés à demi-vie |
WO2023218243A1 (fr) | 2022-05-12 | 2023-11-16 | Avacta Life Sciences Limited | Protéines de fusion de liaison lag-3/pd-l1 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5173414A (en) * | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
GB9027917D0 (en) * | 1990-12-21 | 1991-02-13 | Ici Plc | Expression systems |
US5631162A (en) * | 1993-06-11 | 1997-05-20 | Massachusetts Institute Of Technology | Retroviral vectors for transducing β-globin gene and β-locus control region derivatives |
EP0760861A1 (fr) * | 1994-05-20 | 1997-03-12 | The Board Of Trustees Of The Leland Stanford Junior University | Systeme de replication autonome pour cellules mammaliennes |
US6110666A (en) * | 1994-06-09 | 2000-08-29 | Medical Research Council | Locus control subregions conferring integration-site independent transgene expression abstract of the disclosure |
WO1996017072A2 (fr) * | 1994-11-30 | 1996-06-06 | Chiron Viagene, Inc. | Vecteurs d'alphavirus de recombinaison |
-
1997
- 1997-08-18 EP EP97937661A patent/EP0918874B1/fr not_active Expired - Lifetime
- 1997-08-18 PT PT97937661T patent/PT918874E/pt unknown
- 1997-08-18 AT AT97937661T patent/ATE199570T1/de not_active IP Right Cessation
- 1997-08-18 AU AU40209/97A patent/AU725474B2/en not_active Ceased
- 1997-08-18 DK DK97937661T patent/DK0918874T3/da active
- 1997-08-18 JP JP10510501A patent/JP2000516472A/ja not_active Ceased
- 1997-08-18 DE DE69704206T patent/DE69704206T2/de not_active Expired - Fee Related
- 1997-08-18 CA CA002263796A patent/CA2263796A1/fr not_active Abandoned
- 1997-08-18 ES ES97937661T patent/ES2157084T3/es not_active Expired - Lifetime
- 1997-08-18 WO PCT/GB1997/002213 patent/WO1998007876A2/fr active IP Right Grant
-
2001
- 2001-05-08 GR GR20010400686T patent/GR3035838T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE199570T1 (de) | 2001-03-15 |
PT918874E (pt) | 2001-08-30 |
WO1998007876A2 (fr) | 1998-02-26 |
GR3035838T3 (en) | 2001-08-31 |
DE69704206T2 (de) | 2001-08-30 |
ES2157084T3 (es) | 2001-08-01 |
CA2263796A1 (fr) | 1998-02-26 |
AU4020997A (en) | 1998-03-06 |
EP0918874B1 (fr) | 2001-03-07 |
DE69704206D1 (de) | 2001-04-12 |
JP2000516472A (ja) | 2000-12-12 |
WO1998007876A3 (fr) | 1998-04-16 |
EP0918874A2 (fr) | 1999-06-02 |
AU725474B2 (en) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0918874T3 (da) | Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression | |
EP1176195A4 (fr) | Methode de regulation de l'activite d'une molecule immunologiquement fonctionnelle | |
EP0677870A3 (fr) | Attaque contrÔlée d'oxides utilisant des réacteurs en phase gazeuse. | |
PT805822E (pt) | Eritropoietina seca por pulverizacao | |
KR950009326U (ko) | 단일 제어 카트리지 밸브(Single Control Cartridge Valve) | |
AU6421399A (en) | Interpretive language architecture for controlling the attributes of a physical,chemical, or thermodynamic process | |
TW359059B (en) | Method and arrangement for encoding a video signal | |
EP0675066A3 (fr) | Système de contrÔle pour contrÔle actif de vibrations sur ascenseur. | |
YU59604A (sh) | Fibrinolitički aktivan polipeptid | |
AU2678195A (en) | Locus control subregions for integration-site independent transgene expression | |
EP0598133A4 (fr) | Remede contre les plaies. | |
EP0654725A3 (fr) | Mécanisme pour commander la position de leviers. | |
NO990311L (no) | F°ring for skuff | |
EP1010761A4 (fr) | Gene | |
AU689803B2 (en) | Plant-derived phospholipase D gene | |
EP0678905A3 (fr) | Joint pour le contrÔle de la dissolution d'une plaquette dans un procédé de micro-usinage. | |
ES2188899T3 (es) | Agente antifungico. | |
IT1295436B1 (it) | Valvola di controllo. | |
WO2000032864A3 (fr) | Commande de lave-linge | |
AU2001234862A1 (en) | Interface assembly for lapping control feedback | |
AU1110595A (en) | Utilization of phenyl compounds for the control of phytoparasite nematodes | |
FI941394A (fi) | Peptidejä,jotka kykenevät säätelemään akrosomireaktiota | |
ES2149353T3 (es) | Polimorfos a y b de 1-(difenilmetil)-4-(3-(2-fenil-1,3-dioxolan-2-il)propil)piperazina. | |
EP0609766A3 (fr) | Procédé de stabilisation de l'antigénéité de myeloperoxidase. | |
NO160525C (no) | Anvendelse av en rekombinant bakteriofag som inneholder alfa- amylasegenet, til hetorolog transformasjon av en vertsmikroorganisme av slekten bacillus. |